|
Cohorts
|
Number
|
Day 7 (p value)
|
Day 14 (p value)
|
Day 21 (p value)
|
Day 28 (p value)
|
Day 35 (p value)
|
|---|
|
Control
|
5
|
9.92 ± 5.82 (1)
|
38.30 ± 29.00 (1)
|
259.43 ± 171.47 (1)
|
942.92 ± 745.58 (1)
|
1962.19 ± 1326.31 (1)
|
|
Anti-TGF-β
|
5
|
5.19 ± 4.00 (0.142)
|
14.60 ± 9.08 (0.056)
|
63.57 ± 40.38 (0.053)
|
487.30 ± 530.90 (0.353)
|
984.64 ± 719.09 (0.211)
|
|
Anti-CD25
|
5
|
2.22 ± 2.90 (0.012)
|
3.97 ± 4.28 (0.005)
|
90.74 ± 123.26 (0.104)
|
257.59 ± 310.82 (0.104)
|
774.40 ± 867.07 (0.108)
|
|
Anti-TGF-β+ anti-CD25
|
6
|
0.01 ± 0.004 (0.001)
|
0.46 ± 0.85 (0.002)
|
48.31 ± 115.88 (0.028)
|
120.39 ± 288.12 (0.035)
|
160.81 ± 347.21 (0.008)
|
- Italic values indicate significance of p value (p<0.05)
